Publications by authors named "Yohei Ota"

Claim this Profile
[
[A Case of cy1 Advanced Gastric Cancer That Achieved CR after Chemotherapy Via an Enterostomy].
Hidetaka A Ono, Yohei Ota, Hirokazu Suwa, Kazunori Nojiri, Kenichi Yoshida

Gan To Kagaku Ryoho· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Investigation of Preoperative Chemotherapy Using Enterostomy for Advanced Gastric Cancer with Stenosis].
Hidetaka A Ono, Yohei Ota, Hirokazu Suwa, Kazunori Nojiri, Kenichi Yoshida

Gan To Kagaku Ryoho· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma.
Ryusei Matsuyama, Ryutaro Mori, Yohei Ota, Yuki Homma, Yasuhiro Yabusita

Ann Surg Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic drain management after pancreaticoduodenectomy without focusing on the drain fluid amylase level: A prospective validation study regarding criteria for early drain removal that do not include the drain fluid amylase level.
Koichi Taniguchi, Ryusei Matsuyama, Yasuhiro Yabushita, Yuki Homma, Yohei Ota

J Hepatobiliary Pancreat Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Simple and Easily Reproducible Model of Reversible Obstructive Jaundice in Rats.
Seigo Hiratani, Ryutaro Mori, Yohei Ota, Ryusei Matsuyama, Takafumi Kumamoto

In Vivo· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma.
Ryusei Matsuyama, Daisuke Morioka, Ryutaro Mori, Yasuhiro Yabushita, Seigo Hiratani, Yohei Ota

World J Surg· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-institution experience with gemcitabine-cisplatin combination therapy as a second-line treatment for patients with unresectable biliary tract cancer after failure of gemcitabine-S-1 combination therapy: a prospective feasibility study.
Ryusei Matsuyama, Daisuke Morioka, Ryutaro Mori, Seigo Hiratani, Yasuhiro Yabushita, Yohei Ota

Cancer Chemother Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: With Special Reference to Hepatic Arterial Resection and Reconstruction.
Ryusei Matsuyama, Ryutaro Mori, Yohei Ota, Yuki Homma, Takafumi Kumamoto

Ann Surg Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombomodulin improves rat survival after extensive hepatectomy.
Yohei Ota, Takafumi Kumamoto, Atsushi Ishibe, Kazuteru Watanabe, Ryutarou Mori, Toru Kubota

J Surg Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a case.
Yohei Ota, Ryusei Matsuyama, Koichi Taniguchi, Michio Ueda, Kazuhisa Takeda

Clin J Gastroenterol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Long-term survival of a breast cancer patient with liver metastasis treated with trastuzumab and Paclitaxel].
Yohei Ota, Takashi Ishikawa, Akimitsu Yamada, Daisuke Shimizu, Satoshi Hasegawa

Gan To Kagaku Ryoho· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis